ACUT

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Accustem Sciences (ACUT) Ownership - Who owns Accustem Sciences?

Accustem Sciences Inc is a life sciences company that focuses on enhancing cancer patient outcomes through diagnostic, pharmaceutical, and medical device products... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

5 Penn Plaza

Phone

N/A

Employees

Web

https://www.accustem.com

Details

Group

Domestic Stock Funds

Fundamentals

ACUT

Capitalization

6.78M

P/E Ratio

N/A

Risk (Beta)

2.13

Dividend Yield

N/A

Total Cash

37.1K

Total Cash/Share

0.00

Total Debt

57.6K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

ROE

N/A

Book Value

-3.19M

P/B Ratio

N/A

Cash Flow

N/A

Earnings

-0.12

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

11.3K

Current Ratio

0.03

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-1.38M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-763.18

Shares Held By Institutions

Shares Outstanding - Current

12.1M

Total Liabilities

3.3M

Total Volume MTD

N/A

Value

Gain YTD

25.000

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology